Vopak reported 1Q25 which were in line with proportional EBITDA of €300m vs consensus of €292m. So far company foresees only limited impact in the short term linked to trade tariff uncertainty. EBITDA outlook maintained even when discounting less favourable FX rates. Indian AVTL on track for IPO in 1H25 following conditional approval by regulator. Occupancy rates holding up well at 92% vs. 93% last quarter. The Q&A in the analyst call further comforted our scenario. We reiterate Buy rating and €...
Resolutions passed by Vopak’s Annual General Meeting Resolutions passed by Vopak’s Annual General MeetingRotterdam, the Netherlands, 23 April 2025 The Annual General Meeting of Koninklijke Vopak N.V. (Royal Vopak) held on 23 April 2025 passed the following resolutions: Positive advisory vote implementation remuneration policy for the 2024 financial year. Adoption of the financial statements for the 2024 financial year. Approval of the proposed dividend. A dividend of EUR 1.60 per ordinary share with a nominal value of EUR 0.50 will be distributed wholly in cash on 2 May 2025. As fro...
AkzoNobel: 3% beat on 1Q25 Adj. EBITDA, FY25 guidance maintained at +€1.55bn. BE Semiconductor Industries: 1Q25 results - extending the downcycle. Corbion: Apogee. Just Eat Takeaway.com: 1Q25 Trading Update - no impact on the bid. Kinepolis: 1Q25 preview. KPN: 1Q25 preview. Randstad: Strong 9% high quality beat on 1Q25, 2Q25 outlook looks a touch below. Vår Energi: Fine start of the year, more to come. Vopak: Reasonable start, cashflow developing nicely.
Vopak reports strong Q1 2025 results, commissioning capacity in existing locations The Netherlands, 23 April 2025Vopak reports strong Q1 2025 results, commissioning capacity in existing locations Key highlights Q1 2025 Improve Net profit -including exceptional items- Q1 2025 of EUR 100 million and EPS of EUR 0.85 Proportional EBITDA -excluding exceptional items1- increased in Q1 2025 by EUR 23 million to EUR 300 million Agreements were signed for a new debt issuance of around EUR 560 million equivalent, improving Vopak's debt maturity profile and financial flexibility Grow Expandi...
We keep our HOLD and €12.5 target price on Sligro. We continue to view the equity story as a margin recovery play but note that improvements in FY25F should be more modest than previously expected due to the ongoing difficult macroeconomic environment. We cut our Adj. EBITDA forecasts by 7% and 11% for FY25F and 2026F. Sligro's balance sheet offers limited room for inorganic growth or for more cash return to shareholders, the group leverage ratio standing at 3.4x NFD/EBITDA at the end of 2024. S...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.